EMA settles Brexit dispute; issues drug shortages guidance

The European Medicines Agency (EMA) has ended a Brexit legal dispute over its Canary Wharf, London headquarters.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Big Pharma

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

16 August 2019 Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Big Pharma

No-deal Brexit: MHRA would take on EMA functions for UK

24 August 2018 The UK will fall outside of the European Medicines Agency in the event of a no-deal Brexit, leaving the Medicines and Healthcare Products Regulatory Agency to take on the functions currently undertaken by the EU for medicines on the UK market.

Big Pharma

London loses EMA to Amsterdam

21 November 2017 The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.

More on this story

Big Pharma

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

16 August 2019 Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Big Pharma

No-deal Brexit: MHRA would take on EMA functions for UK

Big Pharma

London loses EMA to Amsterdam

21 November 2017 The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.

More on this story

Big Pharma

Pharma bodies sign NDAs with UK govt over no-deal Brexit plans

16 August 2019 Several pharma bodies have signed non-disclosure agreements which prevent them from disclosing the UK government’s plans for a no-deal Brexit.

Big Pharma

No-deal Brexit: MHRA would take on EMA functions for UK

Big Pharma

London loses EMA to Amsterdam

21 November 2017 The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.